Annual CFF
-$24.09M$303.25M-108.63%
Summary
- Current Value
- As of today, ACLX annual cash from financing is -$24.09M, down -108.63% on
- Historical Performance
- ACLX annual cash from financing is down -120.33% over the past 3 years, and down -156.47% over the past 5 years
- All-Time High Comparison
- ACLX annual cash from financing is currently -108.63% below its historical high of $279.16M set on
- 3-Year Low Comparison
- ACLX annual cash from financing is at its 3-year low
- Sector Comparison
- ACLX annual cash from financing is higher than 13.61% of companies in Healthcare sector
Cash From Financing Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | -$24.09M | -108.6% | -120.3% | -156.5% | -156.5% | |
| Quarterly Cash From Financing | $86.10M | +1948.4% | +986.9% | – | – | |
| TTM Cash From Financing | $90.88M | -46.7% | -63.8% | – | – | |
| Price | $68.05 | +3.3% | +111.2% | – | – | |
| Annual Cash From Operations | -$83.47M | -140.2% | -53.9% | -344.6% | -344.6% | |
| Annual Cash From Investing | -$183.05M | -18.5% | -128.9% | -4676.8% | -4676.8% | |
| Annual Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual Total Debt | $54.08M | -44.6% | +10000.0% | +100.0% | +100.0% | |
| Shares Outstanding | 57.82M | +6.5% | +31.1% | +61.8% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $279.16M | -108.6% | |
| 5Y | $279.16M | -108.6% | |
| All | $279.16M | -108.6% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$24.09M | at low | |
| 5Y | -$24.09M | at low | |
| All | -$24.09M | at low |
Cash From Financing History
| Year | Value | Change |
|---|---|---|
| -$24.09M | -108.6% | |
| $279.16M | +10.5% | |
| $252.63M | +113.3% |
| Year | Value | Change |
|---|---|---|
| $118.45M | +184.4% | |
| $41.66M | -2.3% | |
| $42.65M | - |
FAQ
What is the current annual cash from financing of ACLX?
As of today, ACLX annual cash from financing is -$24.09M
What is 1-year change in ACLX annual cash from financing?
ACLX annual cash from financing is down -108.63% year-over-year
What is 3-year change in ACLX annual cash from financing?
ACLX annual cash from financing is down -120.33% over the past 3 years
How far is ACLX annual cash from financing from its all-time high?
ACLX annual cash from financing is currently -108.63% below its historical high of $279.16M set on December 31, 2023
How does ACLX annual cash from financing rank versus sector peers?
ACLX annual cash from financing is higher than 13.61% of companies in Healthcare sector
When is ACLX next annual earnings release?
The next annual earnings release for ACLX is on
Quarterly CFF
$86.10M$75.84M+739.43%
Summary
- Current Value
- As of today, ACLX quarterly cash from financing is $86.10M, up +739.43% on
- Historical Performance
- ACLX quarterly cash from financing is up +1948.43% year-over-year, and up +986.90% over the past 3 years
- All-Time High Comparison
- ACLX quarterly cash from financing is currently -54.35% below its historical high of $188.59M set on
- 3-Year Low Comparison
- ACLX quarterly cash from financing is +925.74% above its 3-year low of -$10.43M reached on
- Sector Comparison
- ACLX quarterly cash from financing is higher than 93.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | $86.10M | +739.4% | +1948.4% | +986.9% | – | |
| Annual Cash From Financing | -$24.09M | – | -108.6% | -120.3% | -156.5% | |
| TTM Cash From Financing | $90.88M | +10000.0% | -46.7% | -63.8% | – | |
| Price | $68.05 | -18.4% | +3.3% | +111.2% | – | |
| Quarterly Cash From Operations | -$49.21M | -23.9% | -260.2% | -195.6% | – | |
| Quarterly Cash From Investing | -$20.03M | -286.4% | -156.0% | +75.4% | – | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | – | |
| Quarterly Total Debt | $51.79M | -1.4% | -20.7% | -40.4% | +100.0% | |
| Shares Outstanding | 57.82M | – | +6.5% | +31.1% | +61.8% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $86.10M | at high | |
| 3Y | $188.59M | -54.4% | |
| 5Y | $188.59M | -54.4% | |
| All | $188.59M | -54.4% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$6.02M | N/A | +1531.0% |
| 3Y | -$10.43M | +925.7% | |
| 5Y | -$10.43M | +925.7% | |
| All | -$10.43M | +925.7% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of ACLX?
As of today, ACLX quarterly cash from financing is $86.10M
What is ACLX quarterly cash from financing most recent change?
ACLX quarterly cash from financing was up +739.43% on September 30, 2025
What is 1-year change in ACLX quarterly cash from financing?
ACLX quarterly cash from financing is up +1948.43% year-over-year
How far is ACLX quarterly cash from financing from its all-time high?
ACLX quarterly cash from financing is currently -54.35% below its historical high of $188.59M set on December 31, 2023
How does ACLX quarterly cash from financing rank versus sector peers?
ACLX quarterly cash from financing is higher than 93.73% of companies in Healthcare sector
When is ACLX next earnings release?
The next earnings release for ACLX is on
TTM CFF
$90.88M$90.76M+72,606.40%
Summary
- Current Value
- As of today, ACLX TTM cash from financing is $90.88M, up +72606.40% on
- Historical Performance
- ACLX TTM cash from financing is down -46.70% year-over-year, and down -63.84% over the past 3 years
- All-Time High Comparison
- ACLX TTM cash from financing is currently -67.44% below its historical high of $279.16M set on
- 3-Year Low Comparison
- ACLX TTM cash from financing is +477.31% above its 3-year low of -$24.09M reached on
- Sector Comparison
- ACLX TTM cash from financing is higher than 85.09% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | $90.88M | +10000.0% | -46.7% | -63.8% | – | |
| Annual Cash From Financing | -$24.09M | – | -108.6% | -120.3% | -156.5% | |
| Quarterly Cash From Financing | $86.10M | +739.4% | +1948.4% | +986.9% | – | |
| Price | $68.05 | -18.4% | +3.3% | +111.2% | – | |
| TTM Cash From Operations | -$198.11M | -67.6% | -1052.0% | -176.0% | – | |
| TTM Cash From Investing | $24.38M | -69.6% | +115.4% | +116.1% | – | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | – | |
| Quarterly Total Debt | $51.79M | -1.4% | -20.7% | -40.4% | +100.0% | |
| Shares Outstanding | 57.82M | – | +6.5% | +31.1% | +61.8% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $90.88M | at high | |
| 3Y | $279.16M | -67.4% | |
| 5Y | $279.16M | -67.4% | |
| All | $279.16M | -67.4% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$24.09M | N/A | +477.3% |
| 3Y | -$24.09M | +477.3% | |
| 5Y | -$24.09M | +477.3% | |
| All | -$24.09M | +477.3% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of ACLX?
As of today, ACLX TTM cash from financing is $90.88M
What is ACLX TTM cash from financing most recent change?
ACLX TTM cash from financing was up +72606.40% on September 30, 2025
What is 1-year change in ACLX TTM cash from financing?
ACLX TTM cash from financing is down -46.70% year-over-year
How far is ACLX TTM cash from financing from its all-time high?
ACLX TTM cash from financing is currently -67.44% below its historical high of $279.16M set on December 31, 2023
How does ACLX TTM cash from financing rank versus sector peers?
ACLX TTM cash from financing is higher than 85.09% of companies in Healthcare sector
When is ACLX next earnings release?
The next earnings release for ACLX is on
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
Data Sources & References
- ACLX Official Website www.arcellx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1786205/000119312525266932/0001193125-25-266932-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1786205/000095017025029150/0000950170-25-029150-index.htm
- ACLX Profile on Yahoo Finance finance.yahoo.com/quote/ACLX
- ACLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aclx